相似文献
1
Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.
Int J Geriatr Psychiatry. 2010 Aug;25(8):780-8. doi: 10.1002/gps.2418.
2
Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease.
Psychogeriatrics. 2019 Jan;19(1):46-54. doi: 10.1111/psyg.12363. Epub 2018 Aug 6.
3
Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
Neurobiol Aging. 2015 Jan;36(1):27-32. doi: 10.1016/j.neurobiolaging.2014.07.019. Epub 2014 Jul 21.
4
White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):822-7. doi: 10.1136/jnnp.2003.019273.
5
Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
Int J Geriatr Psychiatry. 2008 Apr;23(4):387-92. doi: 10.1002/gps.1891.
6
Are the behavioral symptoms of Alzheimer's disease directly associated with neurodegeneration?
J Alzheimers Dis. 2010;21(2):627-39. doi: 10.3233/JAD-2010-100048.
7
Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.
Neurology. 2021 Mar 30;96(13):e1743-e1754. doi: 10.1212/WNL.0000000000011638. Epub 2021 Feb 17.
8
Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease.
Int J Geriatr Psychiatry. 2013 Jan;28(1):18-25. doi: 10.1002/gps.3781. Epub 2012 Mar 7.
9
Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease.
J Alzheimers Dis. 2013;35(1):169-78. doi: 10.3233/JAD-121291.
10
Sleep disturbances are key symptoms of very early stage Alzheimer disease with behavioral and psychological symptoms: a Japan multi-center cross-sectional study (J-BIRD).
Int J Geriatr Psychiatry. 2017 Feb;32(2):222-230. doi: 10.1002/gps.4470. Epub 2016 Mar 21.
引用本文的文献
1
Evaluation of AccuBrain-based MRI quantitative analysis in diagnosing Alzheimer's disease and assessing behavioral and psychological symptoms of dementia.
Aging Clin Exp Res. 2025 Apr 17;37(1):126. doi: 10.1007/s40520-025-03023-6.
2
Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms.
Geroscience. 2025 Feb;47(1):457-482. doi: 10.1007/s11357-024-01359-x. Epub 2024 Sep 27.
3
Correlation between white matter hyperintensity and delusional symptoms in Alzheimer's disease.
BMC Psychiatry. 2023 Dec 6;23(1):914. doi: 10.1186/s12888-023-05420-5.
4
Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment.
J Alzheimers Dis Rep. 2023 Nov 3;7(1):1237-1246. doi: 10.3233/ADR-230073. eCollection 2023.
5
MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer's Disease.
Int J Mol Sci. 2023 Oct 5;24(19):14932. doi: 10.3390/ijms241914932.
6
Decreased myelin proteins in brain donors exposed to football-related repetitive head impacts.
Brain Commun. 2023 Mar 6;5(2):fcad019. doi: 10.1093/braincomms/fcad019. eCollection 2023.
7
Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance.
Int J Mol Sci. 2023 Feb 7;24(4):3325. doi: 10.3390/ijms24043325.
8
Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?-A Narrative Review.
J Clin Med. 2022 Oct 14;11(20):6060. doi: 10.3390/jcm11206060.
9
Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer's Clinical Continuum.
Front Aging Neurosci. 2022 Jun 20;14:899158. doi: 10.3389/fnagi.2022.899158. eCollection 2022.
10
Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
J Alzheimers Dis. 2022;86(3):1415-1426. doi: 10.3233/JAD-215267.
本文引用的文献
1
Neuropsychiatric disorders following vascular brain injury.
Mt Sinai J Med. 2006 Nov;73(7):1006-14.
2
Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study.
Am J Respir Crit Care Med. 2007 Jan 15;175(2):190-5. doi: 10.1164/rccm.200602-270OC. Epub 2006 Oct 26.
3
White matter changes associated with psychotic symptoms in Alzheimer's disease patients.
J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):191-8. doi: 10.1176/jnp.2006.18.2.191.
4
Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome.
Stroke. 2006 Apr;37(4):967-72. doi: 10.1161/01.STR.0000208215.49243.c3. Epub 2006 Mar 16.
5
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
Stroke. 2006 Mar;37(3):836-40. doi: 10.1161/01.STR.0000202585.26325.74. Epub 2006 Jan 26.
6
Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis.
Acta Neurol Scand. 2006 Jan;113(1):40-5. doi: 10.1111/j.1600-0404.2006.00540.x.
7
Anxiety and depression 3 years following stroke: demographic, clinical, and psychological predictors.
J Psychosom Res. 2005 Oct;59(4):209-13. doi: 10.1016/j.jpsychores.2005.02.019.
8
Delusions and hallucinations are associated with worse outcome in Alzheimer disease.
Arch Neurol. 2005 Oct;62(10):1601-8. doi: 10.1001/archneur.62.10.1601.
9
Neuroanatomical correlates of behavioural disorders in dementia.
Brain. 2005 Nov;128(Pt 11):2612-25. doi: 10.1093/brain/awh628. Epub 2005 Sep 29.
10
Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia.
J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1337-41. doi: 10.1136/jnnp.2004.056408.
Zotero 插件